| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Tuesday, August 01, 2023 9:16:42 AM
Anyone predicting good news based upon anything other than blowing hot air should have zero issue clarifying the following without having to get too specific.:
1. Type of news (specific to NWBO) - science, regulatory, earned media coverage, business (buyout, partnership, big whale investor) etc.
2. Type of source - publicly available info subjected to better analysis (this they can get specific on), company source, regulator source, scientist, journalist. The least credible type of source is “a person with smarts and experience looked at this and said” as it is second-hand analysis
3. The time frame [this rumor at least has a clear time frame]
4. Positive or negative [this rumor has that too]
5. Degree of expected impact on the SP
If those 5 are not covered you may be feeling hot air and even with them one ought to be skeptical.
Still the same poster cannot fry wolf as easily over and over if they have to offer broad points that either happened or didn’t instead of vague nonsense like ‘good news’.
1. Type of news (specific to NWBO) - science, regulatory, earned media coverage, business (buyout, partnership, big whale investor) etc.
2. Type of source - publicly available info subjected to better analysis (this they can get specific on), company source, regulator source, scientist, journalist. The least credible type of source is “a person with smarts and experience looked at this and said” as it is second-hand analysis
3. The time frame [this rumor at least has a clear time frame]
4. Positive or negative [this rumor has that too]
5. Degree of expected impact on the SP
If those 5 are not covered you may be feeling hot air and even with them one ought to be skeptical.
Still the same poster cannot fry wolf as easily over and over if they have to offer broad points that either happened or didn’t instead of vague nonsense like ‘good news’.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
